Search - tctmd.com

Displaying 641 - 660 of 1464

Sort: Relevancy | Date

News Daily News

Real-World Study Raises Concerns About Initiating Carotid Stenting in Acute Phase

L.A. McKeown

April 03, 2018

News Daily News

Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR

Michael O'Riordan

March 27, 2018

News Daily News

ESC Releases New Syncope Guidelines

Shelley Wood

March 20, 2018

News Conference News ACC 2018

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Yael L. Maxwell

March 19, 2018

News Conference News ACC 2018

Wearable Cardioverter-Defibrillator Fails to Meet Primary Endpoint in First Randomized Trial

Todd Neale

March 10, 2018

News Conference News CRT 2018

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Shelley Wood

March 07, 2018

News Industry News

REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold

February 26, 2018

News Daily News

Multivessel PCI Improves Outcomes in STEMI Patients With Cardiogenic Shock: Korean Registry

Caitlin E. Cox

February 23, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

News Conference News ISET 2018

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

Caitlin E. Cox

February 08, 2018

News Daily News

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Caitlin E. Cox

February 05, 2018

News Daily News

Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study

Shelley Wood

February 01, 2018

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Michael O'Riordan

January 10, 2018

News Daily News

Competitive Triathletes Show Evidence of Myocardial Fibrosis

Michael O'Riordan

December 25, 2017

News Daily News

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Shelley Wood

December 19, 2017

News Conference News AHA 2017

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

Todd Neale

November 22, 2017

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Todd Neale

November 14, 2017

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

Advertisement

Real-World Study Raises Concerns About Initiating Carotid Stenting in Acute Phase

Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR

ESC Releases New Syncope Guidelines

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Wearable Cardioverter-Defibrillator Fails to Meet Primary Endpoint in First Randomized Trial

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold

Multivessel PCI Improves Outcomes in STEMI Patients With Cardiogenic Shock: Korean Registry

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study

SELUTION™ First-in-Man Study Achieves Primary Endpoint

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Competitive Triathletes Show Evidence of Myocardial Fibrosis

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content